|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Depression | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Depressive Disorder | |||||
| 3 | More general conditions related to this trial | ||||
| Behavioral Symptoms | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Citalopram | |||||
| St. John's Wort | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antidepressive Agents | |||||
| Antidepressive Agents, Second-Generation | |||||
| Central Nervous System Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Neurotransmitter Uptake Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Uptake Inhibitors | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||
| National Center for Complementary and Alternative Medicine (NCCAM) | |||||
| Office of Dietary Supplements (ODS) | |||||